Survival differences among Asian subpopulations in the United States after prostate, XXXX .

@entity1 @entity263 @entity0 @entity5 @entity189 @entity14
BACKGROUND: Information is limited for Asian subgroups regarding survival after diagnosis of the common @entity5 amenable to routine screening. The authors examined survival after @entity189 of the prostate, colon/rectum, breast, and cervix separately for Chinese, Japanese, Filipinos, and non-Hispanic whites in the United States. METHODS: Using data from the Surveillance, Epidemiology, and End Results program, the authors compared the distributions of stage at diagnosis and computed 5-year cause specific survival probabilities, overall and by stage of disease, for @entity5 @entity1 whose diagnosis was in 1988-1994 and who were observed through 1997. RESULTS: Among males, Filipinos were more likely to be diagnosed with advanced stage @entity14 than other Asians and non-Hispanic whites; they also experienced worse survival after these @entity5 . This survival deficit occurred across all stages of @entity14 and remained apparent within distant stage @entity263 . Among females, Chinese were less likely to receive diagnoses of early stage @entity14 than Japanese and Filipinas. In addition, their survival was consistently lower across more advanced stages of disease. Chinese also experienced somewhat worse survival after diagnosis of @entity5 . Japanese were more likely to be diagnosed with early stage @entity189 but also tended to experience better survival after prostate, @entity0 regardless of stage. CONCLUSIONS: Chinese, Japanese, and Filipinos experienced unequal survival after these screenable @entity189 , indicating that certain groups may benefit from more aggressive screening efforts. The heterogeneity of @entity5 outcomes observed within the community classified as Asian reinforces the need for @entity5 statistics to be reported for disaggregated subgroups.
